Showing 1 - 2 results of 2 for search 'R. Rouzier', query time: 0.02s Refine Results
  1. 1
    Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.

    Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay. by D Mouttet, M Laé, M Caly, D Gentien, S Carpentier, H Peyro-Saint-Paul, A Vincent-Salomon, R Rouzier, B Sigal-Zafrani, X Sastre-Garau, F Reyal

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer, in real‐life settings

    Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negativ... by D. Hequet, N. Hajjaji, E. Charafe‐Jauffret, A. Boucrauta, F. Dalenc, V. Nicolai, J. Lopez, O. Tredan, E. Deluche, V. Fermeaux, L. Tixier, A. Cayre, E. Menet, F. Lerebours, R. Rouzier

    Published 2023-08-01
    Get full text
    Article

Search Tools: